Cell line · CVCL_0025
Papers267
1 more article gives this line's RRID in its Methods without naming the line nearby, so it is not listed.
1 to 20 of 267
Download this page as JSON| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| Integrative genomics and experimental validation identify a mechanosensitive gene signature associated with colorectal cancer liver metastasis. | iScience | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Alcohol disrupts spatial coordination of autophagy-lysosome pathways to impair intestinal barrier integrity. | EBioMedicine | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Targeting O6-methylguanine-DNA Methyltransferase Deficiency in Preclinical Models of Extracranial Human Cancers with a Tumor-Selective DNA-Modifying Agent. | Mol Cancer Ther | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Avobenzone induces intestinal injury by targeting ATG14 and impairing mitophagy. | Cell Commun Signal | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Assembled Hyaluronic Acid Therapeutics for Targeting M1 Macrophages and Regulating Immune Homeostasis for Ulcerative Colitis Treatment. | Adv Sci (Weinh) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Customizable host and viral transcript enrichment using CRISPR-Cas9 long-read sequencing for characterization of low-to-moderate abundance isoforms. | NAR Genom Bioinform | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Endogenous CRISPR-Based Removal of Tetracycline Resistance in Bifidobacterium animalis subsp. lactis Through a Safe-by-Design Approach. | Microb Biotechnol | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Calu-3 cells as novel efficient cell culture system for Borna disease virus 1 (BoDV-1). | Virus Res | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Microbial enzyme-responsive inulin nanoparticles for colon-targeted oral delivery of 5-ASA toward improved therapy of inflammatory bowel disease. | Theranostics | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Host cell entry and neutralisation sensitivity of H3N2 influenza A virus subclade K. | NPJ Vaccines | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Bioactive Properties of Achillea biserrata M.Bieb. Extracts: Phytochemical Analysis, Antioxidant Activity, Target Enzyme Inhibition, and Cytotoxic Effects. | Chem Biodivers | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Moxifloxacin-Mediated Downregulation of Intestinal P-Glycoprotein Alters the Pharmacokinetics of Dabigatran Etexilate: Mechanistic Insights in Rats and PBPK Model-Informed Dose Optimization. | Pharmaceutics | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Targeting host lipogenesis with a diarylamide inhibitor disrupts SARS-CoV-2 replication. | iScience | 2026 | Its Methods give the RRID and name the line | PubMed | |
| An epithelial GPR35 isoform supports tumor-associated transcriptional and metabolic phenotypes. | FEBS Lett | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Microbial keystone taxa and metabolic signatures in centenarians regulate intestinal homeostasis during aging. | Imeta | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Exploring the potential role of miR-124 in angiogenesis in colorectal cancer. | J Cancer Res Clin Oncol | 2026 | Its Methods give the RRID and name the line | PubMed | |
| RBMX promotes colorectal liver metastasis by stabilizing MTHFD2 mRNA to regulate redox homeostasis. | Cell Mol Life Sci | 2026 | Its Methods give the RRID and name the line | PubMed | |
| NIR and Oxidative Stress-Modulated Intestinal Peristalsis Motion of Tubular Conductive Thermo-Hydrogel Actuator. | Nanomicro Lett | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Dihydroartemisinin inhibits mutant KRAS to potentiate regorafenib plus anti-PD-1 in KRAS-mutant colorectal cancer liver metastases. | Cell Death Dis | 2026 | Its Methods give the RRID and name the line | PubMed | |
| FUT2-Mediated Fucosylation of OLFM4 Promotes Colon Cancer Cell Differentiation. | Can J Gastroenterol Hepatol | 2026 | Its Methods give the RRID and name the line | PubMed |
cell-lines-2026-11-14-0.1.0
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_0025/papers